Skip to content

About this study

The aim of the present study is to assess the impact of short-term forearm immobilization on forearm muscle glucose uptake and amino acid net balance and kinetics in individuals with T2D compared with a control group with normoglycaemia.

Condition
Healthy, Type 2 Diabetes
Tested
Forearm immobilization
Sponsor
Wageningen University

Who can join

Age
18 to 80 years
Sex
All sexes
Healthy volunteers
Accepted

Inclusion 7

  • Minimum age: 18 years
  • Maximum age: 80 years
  • Study condition: Healthy, Type 2 Diabetes
  • Males and females with or without diagnosed type 2 diabetes
  • Use lifestyle changes, metformin, gliclazide, or a combination thereof as oral glucose-lowering treatments for T2D
  • Aged 18-80 years at the time of signing informed consent
  • 18.5 ≥ BMI ≤ 35 kg·m2

Exclusion 16

  • Type 1 or a genetic form of diabetes
  • Any diagnosed cardiovascular (heart) disease or high blood pressure (≥160 mmHg systolic and/or ≥100 mmHg diastolic)
  • Chronic use of any prescribed or over-the-counter pharmaceuticals (excluding oral contraceptives and contraceptive devices) that interact with muscle substrate metabolism (e.g. selective serotonin reuptake inhibitors)
  • Consumption of a low-carbohydrate diet
  • Smoking or chewing tobacco
  • Known anaemia
  • Regular use of dietary protein and/or amino acid supplements (\>3 times per week)
  • Currently involved in a structured progressive resistance training program (\>3 times per week)
  • A personal or family history of thrombosis (clots)
  • Any previous motor disorders or inborn errors in muscle and/or lipid metabolism
  • History of kidney disease
  • History of liver disease
  • Pregnant or breastfeeding
  • History of any drug or alcohol abuse in the past two years
  • Claustrophobia
  • Unable to give consent

Where

1 site, 1 recruiting

Wageningen University and Research

Wageningen, Gelderland, Netherlands

Recruiting

Contact

Potential match only. Final eligibility is determined by the study team.